GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $28,000 | 0.0% | 636 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $28,000 | 0.0% | 636 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $28,000 | +16.7% | 636 | 0.0% | 0.01% | +20.0% |
| Q3 2021 | $24,000 | -4.0% | 636 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $25,000 | +8.7% | 636 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $23,000 | 0.0% | 636 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $23,000 | -4.2% | 636 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $24,000 | -7.7% | 636 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $26,000 | +8.3% | 636 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $24,000 | -20.0% | 636 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $30,000 | +11.1% | 636 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $27,000 | +8.0% | 636 | 0.0% | 0.01% | +14.3% |
| Q2 2019 | $25,000 | -7.4% | 636 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $27,000 | +12.5% | 636 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $24,000 | -7.7% | 636 | 0.0% | 0.01% | -11.1% |
| Q3 2018 | $26,000 | 0.0% | 636 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $26,000 | +4.0% | 636 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $25,000 | +8.7% | 636 | 0.0% | 0.01% | +11.1% |
| Q4 2017 | $23,000 | -11.5% | 636 | 0.0% | 0.01% | -18.2% |
| Q3 2017 | $26,000 | -3.7% | 636 | 0.0% | 0.01% | -8.3% |
| Q2 2017 | $27,000 | 0.0% | 636 | 0.0% | 0.01% | -7.7% |
| Q1 2017 | $27,000 | +12.5% | 636 | 0.0% | 0.01% | +8.3% |
| Q4 2016 | $24,000 | -11.1% | 636 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $27,000 | -3.6% | 636 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $28,000 | +7.7% | 636 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $26,000 | 0.0% | 636 | 0.0% | 0.01% | -6.7% |
| Q4 2015 | $26,000 | +8.3% | 636 | 0.0% | 0.02% | +7.1% |
| Q3 2015 | $24,000 | -7.7% | 636 | 0.0% | 0.01% | -6.7% |
| Q2 2015 | $26,000 | -10.3% | 636 | 0.0% | 0.02% | -11.8% |
| Q1 2015 | $29,000 | +7.4% | 636 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $27,000 | -60.3% | 636 | -50.0% | 0.02% | -63.8% |
| Q4 2013 | $68,000 | – | 1,272 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |